Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 9/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | MC4R | P32245 | 2/20 | 0.52 |
| ▸ | GHSR | Q92847 | 2/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30919241 | 0.98 | KISS1R (0.55) | KISS1RKMT2AMC4RGHSRNPY1R | |
| SCHEMBL30919236 | 0.98 | KISS1R (0.55) | KISS1RKMT2AMC4RGHSRNPY1R | |
| SCHEMBL29511119 | 0.97 | MC4R (0.54) | KISS1RKMT2AMC4RLTA4H | |
| SCHEMBL29476649 | 0.97 | MC4R (0.54) | KISS1RKMT2AMC4RLTA4H | |
| SCHEMBL31206184 | 0.97 | KISS1R (0.55) | KISS1RKMT2AMC4RGHSR | |
| SCHEMBL29483776 | 0.96 | ACE (0.55) | KMT2A | |
| SCHEMBL29672131 | 0.95 | NPY1R (0.56) | KISS1RKMT2AMC4RGHSRLTA4H | |
| SCHEMBL31165850 | 0.95 | ACE (0.54) | KISS1RKMT2A | |
| SCHEMBL31165874 | 0.95 | ACE (0.54) | KISS1RKMT2A | |
| SCHEMBL31193784 | 0.95 | ACE (0.54) | KISS1RKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117642418-A | Probes and kit for early diagnosis of diffuse large B cell lymphoma | 京东方科技集团股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117642418-A | Probes and kit for early diagnosis of diffuse large B cell lymphoma | 京东方科技集团股份有限公司 | 2024-03-01 | — | — | CN | disclosed |